跳至主要内容
临床试验/NCT01860911
NCT01860911已完成1 期

Regulation of the Plasma Triglyceride Extraction in Muscle in Insulin Resistance

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2013年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Mayo Clinic
入组人数
33
试验地点
1
主要终点
Triglyceride extraction across the forearm

研究概览

简要总结

Increased accumulation of fat into the muscles is associated with what is called insulin-resistant state, which is a pre-diabetic state. The purpose of this research is to find out how fat circulating in the blood following fat consumption is taken up by the muscles in healthy people as well as people that are insulin-resistant. The investigators are specifically interested in how a hormone called insulin is involved in this process. Findings from this research will contribute to our understanding of why insulin-resistant people have increased accumulation of fat in their muscles, and ultimately help to design appropriate interventions to prevent type 2 Diabetes.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Body mass index (BMI): < 25 kg/m2 or > 30 kg/m2;
  • Insulin sensitivity index (ISI): insulin-sensitive ISI ≥ 7, insulin-resistant ISI ≤ 5.

排除标准

  • Medication or supplements known to affect either endothelial function or lipid metabolism (i.e. arginine, protein, fish oil)
  • Acute illness
  • Uncontrolled metabolic disease, including liver or renal disease
  • Atrial fibrillation, history of syncope, limiting or unstable angina, congestive heart failure, known or suspected right-to-left, bi-directional or transient right-to-left cardiac shunts
  • Cardiac pacemaker or other medical device implanted in the body
  • Pulmonary hypertension or other unstable cardiopulmonary conditions
  • ECG documented abnormalities or valvular disease
  • Low hemoglobin or hematocrit (i.e., lower than accepted laboratory values)
  • History of hypertension or elevated blood pressure (systolic, >140 mmHg or a diastolic, >95 mmHg)
  • History of hyperlipidemia or plasma triglyceride concentration >200 mg/dl
  • Diagnosed diabetes, or 2-h plasma glucose >200 mg/dl during an oral glucose tolerance test
  • Current participation in a weight-loss regimen, including extreme dietary practices
  • Use of anabolic steroids or corticosteroids (within 3 months)

研究组 & 干预措施

Insulin-Sensitive

Experimental

One group consists of insulin sensitive volunteers.

干预措施: Insulin (Drug)

Insulin-Sensitive

Experimental

One group consists of insulin sensitive volunteers.

干预措施: NG-monomethyl-L-arginine (Drug)

Insulin-Resistant

Experimental

One group consists of insulin resistant volunteers.

干预措施: Insulin (Drug)

结局指标

主要结局

Triglyceride extraction across the forearm

时间窗: Measured during a 7-hour infusion study

次要结局

  • Muscle microvascular blood volume(Selected 15-minute periods during the 7 hour infusion study)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lori R. Roust

PI

Mayo Clinic

研究点 (1)

Loading locations...

相似试验